92

Search documents
油价预降145元/吨!隔夜原油“飙涨”,92汽油下降或少于0.1元!
Sou Hu Cai Jing· 2025-07-13 07:04
然而,由于国内油价以隔夜原油变化为参考,而原油市场,周四原油下降2.65%后,周五原油价格逆势"飙涨",其中,WTI原油大涨1.88美元,涨幅2.82%, 涨至68.45美元/桶,布伦特原油上涨1.72美元,涨幅2.51%,涨至70.36美元/桶;油价涨幅抹去了周四的降幅,周期内,原油价格持续走高!截至本周,本轮 周期内,WTI原油价格累计上涨5.13%…… 受此因素影响,按照油价形成机制,7月14日,明天,本轮调价周期的第9个工作日,国内原油均价止跌上涨,预估涨至68.27美元/桶,国内汽柴油降价预期 或减至135元/吨,油价降幅或减少至0.1-0.12元/升! 展望后市,本次汽柴油将于7月15日24时准时调价,距离调价仅剩2个工作日,由于本轮周期第9个工作日参考7月11日国际油价上涨2.51-2.82%,下一个工作 日国内油价降幅收窄已经确定! 油价下跌,仅剩2天!今天是7月13日,星期天,距离2025年第14次汽柴油调价,7月15日24时,仅剩2个工作日,本轮周期完成前8个交易日,截至目前,周 期内汽柴油统计预降145元/吨,折合升价,各种油品本轮下降0.11-0.13元/升! 倘若,此次油价降幅落地, ...
每周股票复盘:佳禾食品(605300)使用5,000万元闲置资金进行现金管理
Sou Hu Cai Jing· 2025-07-12 20:55
公司公告汇总:佳禾食品使用5,000万元闲置募集资金购买招商银行结构性存款 截至2025年7月11日收盘,佳禾食品(605300)报收于13.99元,较上周的13.79元上涨1.45%。本周,佳 禾食品7月7日盘中最高价报15.17元。7月10日盘中最低价报13.89元。佳禾食品当前最新总市值63.57亿 元,在饮料乳品板块市值排名12/26,在两市A股市值排名2504/5149。 本周关注点 佳禾食品工业股份有限公司发布了关于使用部分暂时闲置募集资金进行现金管理的进展公告。公司使用 人民币5,000万元闲置募集资金购买了招商银行点金系列看涨两层区间92天结构性存款,产品期限为92 天,预计年化收益率为1.00/1.80%,起息日为2025年7月9日,到期日为2025年10月9日。该事项已经过 公司第三届董事会第四次会议、第三届监事会第三次会议及2024年年度股东大会审议通过。公司募集资 金总额为724,999,998.01元,扣除发行费用后实际募集资金净额为711,090,521.57元。公司已对募集资金 进行专户存储管理,并签订了相关监管协议。公司采取多项措施确保资金安全,包括严格遵守相关法律 法规、跟踪 ...
油价降幅“止减”后,原油大涨2.82%,7月15日下降调减中
Sou Hu Cai Jing· 2025-07-12 20:55
但是,由于7月11日,原油价格逆势上涨,国际油价大涨2.82%,WTI原油冲高至68.45美元/桶!主流观点认为,按照国内油价形成机制,以隔夜原油变化为 引导,下一个交易日,7月14日,下周一,本轮计价周期将迎来第9个工作日,原油均价或将回升至68.27美元/桶左右,参考汽柴油下降预期或将减少至135 元/吨,油价降幅或进一步减少! 如今,距离油价调整仅剩2天时间,本轮周期也进入倒计时,基于原油市场看涨情绪不减,下周初,国际油价仍有上涨的风险!理性来看,7月15日,今年第 14次调价,国内油价下降基本确定,但是,汽柴油降价幅度或再次减少,个人预估,油价最终下降或仅有110元/吨左右,倘若降幅落地,届时,此次92汽油 下降或不足0.1元/升! 油价调整,国内汽柴油以10个交易日调价一次,按照原油市场变化为参考,周期内油价调整不足50元/吨,油价执行搁浅的走势!倘若,油价调整达到50元/ 吨,油价相应进行涨跌调价!据悉,上次汽柴油7月1日调价,虽然,周期内油价大涨610元/吨,涨幅一度达到今年最大上涨的局面,好在,中东局势降温, 原油风险溢价回调,汽柴油最终上涨235元/吨以及225元/吨,油价迎来今年第6次上涨 ...
舜宇光學(2382)震盪走勢持續,密切觀察支撐有效性
Ge Long Hui· 2025-07-11 10:49
舜宇光學(2382)截止14點57分,股價報75.4元。該股在過去五日的振幅達到13%,反映出市場資金參與度逐漸升溫。從技術面來看,支撐位落在69.7及 66.6港元,而阻力位則集中於79.6與83.5港元。目前價格正處於中性偏多的格局,市場等待突破訊號出現。 舜宇光學(02382)近期股價波動為投資者提供了豐富的衍生品交易機會。在認購證方面,法巴認購證15995有5倍槓桿,其行使價設定在76.05港元,不僅槓桿 水準適中,更擁有最低的溢價和引伸波幅,為看好後市的投資者提供了成本效益極佳的投資工具。瑞銀認購證15948雖然槓桿略低為4.5倍,但其引伸波幅與 槓桿的平衡性表現出色,同樣值得關注。看空工具方面,信證認沽證14741以3.3倍槓桿和最低溢價成為對沖風險的首選,行使價設定在73.82港元,適合預期 股價可能回調的投資者。 牛證產品中,滙豐牛證62472以4.8倍實際槓桿領跑市場,收回價設定在62港元,與現價保持安全距離;法巴牛證69791則提供5倍實際槓桿,收回價63港元, 兩者溢價均維持在低位,是佈局反彈行情的優質選擇。 | 14:43 4 | | | 14:43 II ? D | | | | -- ...
劲方医药二次递表港交所:核心产品商业化前景难言乐观 删除专利风险提示“欲盖弥彰”?
Xin Lang Zheng Quan· 2025-07-11 07:09
Core Viewpoint - Jinfang Pharmaceutical Technology (Shanghai) Co., Ltd. has submitted its IPO application to the Hong Kong Stock Exchange, aiming for a listing under the 18A rules, with CITIC Securities as the sole sponsor. This marks the second submission after the previous application lapsed [1][2]. Company Overview - Founded in 2017, Jinfang Pharmaceutical focuses on the development of innovative drugs for oncology, autoimmune, and inflammatory diseases. The company's core product, GFH925, a small molecule selective KRAS G12C protein inhibitor, received approval for marketing in August 2024 [1][3]. Market Competition - The KRAS G12C inhibitor market is becoming increasingly competitive, with several competitors already launched and others in late-stage clinical trials. The commercial prospects for GFH925 are uncertain due to the poor sales performance of existing competitors [2][5][6]. Product Development and Approval - GFH925 is the first KRAS G12C inhibitor approved in China for the second-line treatment of advanced non-small cell lung cancer (NSCLC). However, the product's commercial value remains to be validated [3][6]. Financial Performance - Jinfang Pharmaceutical has reported revenues of 105 million yuan, 73.73 million yuan, 105 million yuan, and 82.14 million yuan for the years 2022, 2023, and the first four months of 2025, respectively. The company has incurred total losses exceeding 1.5 billion yuan over three and a half years [9][10][11]. Patent Risks - GFH925 faces potential patent risks, with only one of five patent families granted authorization. The company has entered agreements to mitigate these risks, but the deletion of risk warnings from the updated prospectus raises concerns [7][8]. Collaborations and Agreements - The collaboration with Innovent Biologics regarding GFH925 has changed, requiring Jinfang Pharmaceutical to pay a termination fee of 20 million USD due to the alteration of rights concerning the product's commercialization [10][11].
军工占比超98%!航空航天ETF(159227)多只成分股飘红
Xin Lang Cai Jing· 2025-07-11 06:39
航空航天ETF(159227)跟踪国证航天指数,申万一级行业中,国防军工权重占比高达98.2%,是全市 场最"纯"的军工类ETF。聚焦军工领域的空天力量,在申万二级行业中的"航空+航天装备"权重高达 66.5%,且是跟踪该指数规模最大的ETF产品。 数据显示,截至2025年6月30日,国证航天航空行业指数(CN5082)前十大权重股分别为光启技术 (002625)、中航沈飞(600760)、航发动力(600893)、中航西飞(000768)、中航机载(600372)、航天电子 (600879)、中航成飞(302132)、中航高科(600862)、中兵红箭(000519)、中国卫星(600118),前十大权重 股合计占比49.42%。 消息面上,7月9日下午,中国航天员科研训练中心在北京航天城举行神舟十九号乘组与记者见面会,航 天员蔡旭哲、宋令东、王浩泽太空归来后首次公开亮相,并分享183天"太空出差"的经历与感悟。 中信建投证券表示,在全球军费持续增长的背景下,中国军贸迎来DeepSeek时刻,体系化出口成为大 势所趋。技术层面,中国装备通过实战验证打破"低端廉价"标签,对标国际性价比凸显;服务模式上, 从交 ...
军工板块午后走强,航空航天ETF(159227)连续吸金近3亿,全市场军工含量最高
Mei Ri Jing Ji Xin Wen· 2025-07-11 06:38
Group 1 - The military industry sector is experiencing a rise, with the Aerospace ETF (159227) increasing by 0.64% and achieving a trading volume of 73.66 million yuan, leading its category [1] - The Aerospace ETF has seen a continuous inflow of funds for 11 trading days, totaling 293 million yuan, with a current scale of 546 million yuan, making it the largest in its category [1] - The visit of the Shandong aircraft carrier group to Hong Kong, coinciding with significant anniversaries, has boosted public interest and showcased national defense achievements, providing momentum for the military industry [1] Group 2 - According to Shenwan Hongyuan Securities, the military industry's fundamentals are entering an upward cycle, driven by domestic demand from military construction [2] - The current phase of military development focuses on "mechanization + informatization," with expectations to transition into the next cycle characterized by "intelligent + unmanned" systems, enhancing domestic demand and ensuring growth in the military sector [2]
换手近20%!港股通科技ETF(159262)盘中上涨1.10%,跟踪指数恒生港股通科技同类表现居前
Xin Lang Cai Jing· 2025-07-11 03:47
Group 1 - The Hong Kong Stock Connect Technology ETF (159262) has seen a 1.10% increase, with notable gains from companies like SenseTime-W and Oriental Selection exceeding 5% [1] - The Hang Seng Stock Connect Technology Index (HSSCITI) has outperformed other indices, rising over 1% during trading [1] - The trading volume for the Hong Kong Stock Connect Technology ETF reached 2.62 billion, indicating active market participation [1] Group 2 - The HSSCITI's top ten weighted stocks account for 75.01%, with major players like Kuaishou-W and SMIC leading the pack [2] - The concentration of AI leaders such as Xiaomi, Alibaba, and Tencent exceeds 30% within the top-weighted stocks, highlighting a strong focus on technology [2] - The Hong Kong technology sector is currently benefiting from the AI innovation wave, with historical trends suggesting potential for significant returns [2] Group 3 - Long-term trends indicate a rising premium for China's technology sector, with notable excess returns since 2005 [3] - The technology sector has shown high elasticity and sustainability during various market cycles [3] - New industries such as artificial intelligence and humanoid robotics are gaining policy support, indicating a shift towards localization in core technology sectors [3] Group 4 - The Hong Kong Stock Connect Technology ETF is positioned to capitalize on the "pure technology revolution" opportunities presented by the AI era [4]
盘中重获净流入!中证红利质量ETF(159209)延续强势,7月14日首次分红登记
Sou Hu Cai Jing· 2025-07-11 03:26
Core Viewpoint - The recent performance of the market indicates a strong interest in dividend assets, with specific ETFs showing positive returns and consistent dividend distributions [1]. Group 1: ETF Performance - The CSI Dividend Quality ETF (159209) increased by 0.59% as of 11:12 AM on July 11, with net inflows observed during the trading session [1]. - The CSI Dividend Quality ETF announced its first dividend distribution of the year, with a payout of 0.003 yuan per share, resulting in a monthly dividend yield of 0.30%, with the record date set for July 14 [1]. - The Hong Kong Dividend Low Volatility ETF (520550) also declared its third dividend distribution of the year, with a payout of 0.004 yuan per share and a monthly dividend yield of 0.35% [1]. Group 2: Market Analysis - Recent data shows that dividend assets have attracted significant capital, driven by a decline in risk-free interest rates, making equity assets more attractive in terms of investment value [1]. - The current equity risk premium (ERP) for A-shares is at a historical high, highlighting the long-term allocation value of dividend assets [1]. - A combination of CSI Dividend and Hong Kong dividend assets can facilitate cross-asset allocation, potentially reducing portfolio volatility over the long term [1]. Group 3: Investment Characteristics - As "dividend-type" assets, ETFs offer low fees and stable, frequent dividend distributions, enhancing the holding experience for long-term investors [1].
科饶恩门窗董事长王玉亮:以碳塑共生绘蓝图 超低能耗产品践行绿色未来
Sou Hu Cai Jing· 2025-07-11 02:51
2025 年 7 月 8 日,第 27 届中国建博会(广州)在广交会展馆盛大启幕,以"建装理想家,服务新格局"为主题,展览面积达50万平方米,参展企业近2000 家,预计吸引逾 20 万海内外专业观众。本届展会定位"冠军企业首秀平台",全新升级为室内空间、门窗户外、材艺智造三大生态,构建"三链三联"六大 IP,举办超70场高端活动,全方位赋能行业发展。 搜狐焦点家居以"破局新生态 领航向未来"为主题,深入探寻这一引领潮流趋势的家居盛宴上,主流家居品牌的潮思与谋略。此次盛会,科饶恩超低能耗门 窗以"碳塑共生、窗见未来"为主题,打造"城市建筑绿色未来"概念馆,携 92、80、70 等传统被动式超低能耗系列门窗及ZEW103MD⁺外扣铝超低能耗被动 窗、ES100MD⁺极窄系列新品亮相广交会展馆,凭借差异化的产品体系与沉浸式的展馆设计,吸引众多海内外客商驻足交流,现场洽谈氛围热烈。展会期 间,搜狐焦点家居有幸采访到科饶恩门窗董事长王玉亮,一同深入探讨科饶恩在此次展会上的精彩呈现与未来布局。 【搜狐焦点家居】:王总您好,非常荣幸能在科饶恩的展位与您交流。一来到咱们展位,就能感受到与众不同的氛围,无论是 "城市建筑绿色 ...